Autopsy report · NCT02414698

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

“Integral investigator left study; could not continue recruiting.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 2 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 4 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Montefiore Medical Center

Sponsor type

University, hospital or other

Conditions

Lumbar Herniated Disc

Interventions

Percutaneous Hydrodiscectomy; TESI

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• TubeClear® Evaluation in Pediatric Patients (Phase I)
  “Unable to recruit; study determined not feasible to continue” (71% match in meaning)
• Exercise Therapy for Asthma (ETA Trial)
  “Study proved difficult to recruit” (66% match in meaning)
• The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression
  “the study has stopped due to no recruitment” (66% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (65% match in meaning)
• An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
  “Retirement of former Qualified Investigator and lack of resources to complete study” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.